Data / Drug companies / Glaxo Operations Uk Ltd
Glaxo Operations Uk Ltd: 31 products in the FDA NDC directory, labeler code 63379
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Glaxo Operations Uk Ltd (labeler code 63379) lists 31 products in the FDA National Drug Code Directory. By type: 23 drugs for further processing, 8 bulk ingredients. Its main marketing category is drugs for further processing. The newest product started marketing on March 17, 2026.
The request: Watch Glaxo Operations Uk Ltd (FDA labeler code 63379): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 63379
- Products in commercial distribution
- 31
- Packages
- 36
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 1
- Products with a marketing end date set
- 2
- Earliest marketing start
- January 1, 2004
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Drugs for further processing | 23 | 74.2% |
| Bulk ingredients | 8 | 25.8% |
Products by type
| Type | Products | Share |
|---|---|---|
| Drugs for further processing | 23 | 74.2% |
| Bulk ingredients | 8 | 25.8% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 19 | 61.3% |
| Powder | 8 | 25.8% |
| Spray, metered | 2 | 6.5% |
| Cream | 1 | 3.2% |
| Tablet, for suspension | 1 | 3.2% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Linerixibat | 63379-119 | Tablet, film coated | Drugs for further processing | March 17, 2026 |
| Vilanterol trifenatate | 63379-114 | Powder | Bulk ingredients | January 1, 2024 |
| Umeclidinium bromide | 63379-113 | Powder | Bulk ingredients | January 1, 2024 |
| Daprodustat | 63379-110 | Tablet, film coated | Drugs for further processing | February 1, 2023 |
| Daprodustat | 63379-109 | Tablet, film coated | Drugs for further processing | February 1, 2023 |
| Daprodustat | 63379-108 | Tablet, film coated | Drugs for further processing | February 1, 2023 |
| Daprodustat | 63379-107 | Tablet, film coated | Drugs for further processing | February 1, 2023 |
| Daprodustat | 63379-106 | Tablet, film coated | Drugs for further processing | February 1, 2023 |
| Cabotegravir sodium | 63379-079 | Tablet, film coated | Drugs for further processing | January 15, 2021 |
| Dolutegravir sodium | 63379-077 | Tablet, for suspension | Drugs for further processing | June 12, 2020 |
| Eltrombopag olamine | 63379-090 | Tablet, film coated | Drugs for further processing | January 1, 2020 |
| Eltrombopag olamine | 63379-089 | Tablet, film coated | Drugs for further processing | January 1, 2020 |
| Docosanol | 63379-085 | Cream | Drugs for further processing | January 1, 2020 |
| Fluticasone furoate | 63379-084 | Spray, metered | Drugs for further processing | January 1, 2020 |
| Fluticasone furoate | 63379-083 | Spray, metered | Drugs for further processing | January 1, 2020 |
| Fluticasone furoate | 63379-112 | Powder | Bulk ingredients | November 1, 2018 |
| Dolutegravir sodium and rilpivirine hydrochloride | 63379-072 | Tablet, film coated | Drugs for further processing | November 21, 2017 |
| Dolutegravir sodium | 63379-063 | Tablet, film coated | Drugs for further processing | June 9, 2016 |
| Dolutegravir sodium | 63379-062 | Tablet, film coated | Drugs for further processing | June 9, 2016 |
| Abacavir sulfate | 63379-049 | Powder | Bulk ingredients | August 4, 2014 |
| Zanamivir | 63379-028 | Powder | Bulk ingredients | June 30, 2014 |
| Dutasteride | 63379-016 | Powder | Bulk ingredients | May 16, 2014 |
| Salbutamol sulphate | 63379-007 | Powder | Bulk ingredients | May 6, 2014 |
| Fluticasone propionate | 63379-001 | Powder | Bulk ingredients | April 18, 2014 |
| Dolutegravir sodium | 63379-067 | Tablet, film coated | Drugs for further processing | August 13, 2013 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.